Condition: Type 2 Diabetes · Sponsor: Eli Lilly and Company
The purpose of this study is to measure the change in hemoglobin A1c (HbA1c) with LY3457263 compared with placebo in participants with type 2 diabetes who are not at HbA1c goal when treated with a stable dose of semaglutide or tirzepatide. Participation in the study will last about 9 months.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Helios Clinical Research - Phoenix | Phoenix, Arizona, United States | Recruiting |
| Wolverine Clinical Trials | Santa Ana, California, United States | Recruiting |
| Renstar Medical Research | Ocala, Florida, United States | Recruiting |
| Oviedo Medical Research | Oviedo, Florida, United States | Recruiting |
| Balanced Life Health Care Solutions/SKYCRNG | Lawrenceville, Georgia, United States | Recruiting |
| Physicians Research Associates | Lawrenceville, Georgia, United States | Recruiting |
| Rophe Adult and Pediatric Medicine/SKYCRNG | Union City, Georgia, United States | Recruiting |
| North Georgia Clinical Research | Woodstock, Georgia, United States | Recruiting |
| Elite Clinical Trials | Rexburg, Idaho, United States | Recruiting |
| Investigators Research Group | Brownsburg, Indiana, United States | Recruiting |
| Clinical Research of Philadelphia | Pennington, New Jersey, United States | Recruiting |
| NYC Research INC | Long Island City, New York, United States | Recruiting |
+ 48 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06897475